Patiromer

4 trials 2 recruiting VVarious

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

2 Completed trials

4 Sponsors

12 Countries

Phase III

Phase II

Phase III: 2 Phase II: 2

Indications tested

Hyperkalaemia 1

Sponsors using this IMP

Fundacion Para La Investigacion Biomedica De Cordoba 1 Istituto Di Ricerche Farmacologiche Mario Negri 1 Mario Negri Institute For Pharmacological Research IRCCS 1 Vifor Pharma Inc. 1

All trials

4 total

Effect of patiromer in children under 12 years of age with high blood potassium levels Recruiting

2023-505252-21-00 Phase II 11 countries Vifor Pharma Inc.
Impact of Patiromer treatment on dietary Potassium intake restriction and health-related quality of life and nutrition in patients on Chroni… Recruiting

2025-521378-33-00 Phase III 1 country Istituto Di Ricerche Farmacologiche Mario Negri
Double-blind, placebo-controlled clinical trial to determine the effect of Patiromer on vascular function and its relationship with mineral … Ended

2023-503941-69-00 Phase II 1 country Fundacion Para La Investigacion Biomedica De Cordoba
A Prospective, double-blind, randomized, single centre trial to evaluate the rate of RAAS inhibitor withdrawal or down-titration in non-dial… Ended

2023-503984-41-00 Phase III 1 country Mario Negri Institute For Pharmacological Research IRCCS

Showing 1–4 of 4 trials

← All drugs A–Z